Managing CNS Metastases in EGFR-Positive NSCLC

The Implications of Recent Datasets for the Current and Future Management of NSCLC EGFR MutationsПодробнее

Current and Future Management of Non-Small Cell Lung Cancer with an EGFR MutationПодробнее

Current and Future Management of Non-Small Cell Lung Cancer with an EGFR MutationПодробнее

Treatment & Management Of Lung Cancer Archives 2022 - 27 JanПодробнее

How Metastatic Brain Tumors Affect Your Lung Cancer CareПодробнее

Live Webinar: Clinical Management of Common Cancers Newer PerspectiveПодробнее

Newer Paradigms in the Management of mNSCLC 2022 || 26 NovПодробнее

Lung Cancer | Striving for Consensus on the Management of ALK-Positive Lung CancerПодробнее

Managing ALK+ Lung Cancer: Insights from Dr. Ankur Punia | Oncology Perspective 2024Подробнее

Striving for Consensus on the Management of ALK-Positive Lung CancerПодробнее

Lung Cancer Management 2022 _ 16 February 2022 _ Dr Rahul Sud _ SoMex _ HCMPLПодробнее

Management of Epidermal Growth Factor Receptor (EGFR) - Mutated Non-small-cell Lung Cancer (NSCLC)Подробнее

Lung Cancer Management 2022 _ 16 February 2022 _ Dr Rahul Sud _ SoMex _ HCMPLПодробнее

Part 6 - Optimal Management of EGFR Mutation Positive Advanced Lung Cancer - Dr Shyam AggarwalПодробнее

Recent Update in the Management of Lung Cancer 15 Jan 2022Подробнее

Webinar on Lung Cancer ManagementПодробнее

Insights into the management of ALK+ advanced NSCLCПодробнее

Recent updates in management of Lung Cancer 23 feb 2022Подробнее

New Horizons In The Management of Breast and Lung CancerПодробнее

Practice-Impacting Data on Managing Lung Cancer Brain MetastasesПодробнее